Drug trial offers hope to nerve-illness sufferers

A landmark British trial could offer new hope for people with motor neurone disease, the devastating nerve illness suffered by scientist Professor Stephen Hawking.

The 18-month, £1m (€1.27m) study will test whether the drug lithium can extend the lives of patients who often survive little more than a year after diagnosis.